DoubleLine ETF Adviser’s Merck MRK Stock Holding History

DoubleLine ETF Adviser’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.72M	Buy	+30,910	New	+$3.57M	1.41%	15

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

DoubleLine ETF Adviser's MRK Position: Q1 2026 in Review

DoubleLine ETF Adviser opened a new position in Merck (MRK) in Q1 2026: 30,910 shares worth $3.72M. The stake represents 1.41% of the portfolio and ranks #15 among its holdings.

3,777 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

DoubleLine ETF Adviser held 30,910 shares of Merck worth $3.72M as of Q1 2026.
Merck was a new DoubleLine ETF Adviser position in Q1 2026.
Merck made up 1.41% of DoubleLine ETF Adviser's portfolio in Q1 2026, its #15 holding.
3,777 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q1 2026, filed 15 May 2026.